vs

Side-by-side financial comparison of LXP Industrial Trust (LXP) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

LXP Industrial Trust is the larger business by last-quarter revenue ($86.7M vs $76.2M, roughly 1.1× VIEMED HEALTHCARE, INC.). LXP Industrial Trust runs the higher net margin — 33.2% vs 7.4%, a 25.8% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -14.0%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 0.3%).

LXP Industrial Trust is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality industrial real estate assets, primarily distribution centers, logistics facilities, and light industrial properties across key markets in the United States. Its tenant base covers e-commerce, third-party logistics, and advanced manufacturing sectors, delivering stable long-term returns for its investors.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

LXP vs VMD — Head-to-Head

Bigger by revenue
LXP
LXP
1.1× larger
LXP
$86.7M
$76.2M
VMD
Growing faster (revenue YoY)
VMD
VMD
+39.5% gap
VMD
25.5%
-14.0%
LXP
Higher net margin
LXP
LXP
25.8% more per $
LXP
33.2%
7.4%
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
0.3%
LXP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LXP
LXP
VMD
VMD
Revenue
$86.7M
$76.2M
Net Profit
$28.8M
$5.6M
Gross Margin
81.5%
57.9%
Operating Margin
34.6%
11.0%
Net Margin
33.2%
7.4%
Revenue YoY
-14.0%
25.5%
Net Profit YoY
30.7%
EPS (diluted)
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LXP
LXP
VMD
VMD
Q4 25
$86.7M
$76.2M
Q3 25
$86.9M
$71.9M
Q2 25
$87.7M
$63.1M
Q1 25
$88.9M
$59.1M
Q4 24
$100.9M
$60.7M
Q3 24
$85.6M
$58.0M
Q2 24
$85.8M
$55.0M
Q1 24
$86.3M
$50.6M
Net Profit
LXP
LXP
VMD
VMD
Q4 25
$28.8M
$5.6M
Q3 25
$36.3M
$3.5M
Q2 25
$29.1M
$3.2M
Q1 25
$19.0M
$2.6M
Q4 24
$4.3M
Q3 24
$6.3M
$3.9M
Q2 24
$5.4M
$1.5M
Q1 24
$-269.0K
$1.6M
Gross Margin
LXP
LXP
VMD
VMD
Q4 25
81.5%
57.9%
Q3 25
82.3%
57.5%
Q2 25
81.9%
58.3%
Q1 25
80.7%
56.3%
Q4 24
85.3%
59.5%
Q3 24
82.5%
59.3%
Q2 24
82.0%
59.8%
Q1 24
82.4%
58.9%
Operating Margin
LXP
LXP
VMD
VMD
Q4 25
34.6%
11.0%
Q3 25
50.4%
7.8%
Q2 25
33.7%
8.1%
Q1 25
21.8%
6.5%
Q4 24
10.6%
Q3 24
7.9%
9.7%
Q2 24
6.9%
6.6%
Q1 24
1.0%
4.4%
Net Margin
LXP
LXP
VMD
VMD
Q4 25
33.2%
7.4%
Q3 25
41.7%
4.9%
Q2 25
33.2%
5.0%
Q1 25
21.4%
4.4%
Q4 24
7.1%
Q3 24
7.4%
6.7%
Q2 24
6.3%
2.7%
Q1 24
-0.3%
3.2%
EPS (diluted)
LXP
LXP
VMD
VMD
Q4 25
$0.14
Q3 25
$0.12
$0.09
Q2 25
$0.09
$0.08
Q1 25
$0.06
$0.06
Q4 24
$0.10
Q3 24
$0.02
$0.10
Q2 24
$0.01
$0.04
Q1 24
$-0.01
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LXP
LXP
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$170.4M
$13.5M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$2.0B
$141.5M
Total Assets
$3.5B
$199.2M
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LXP
LXP
VMD
VMD
Q4 25
$170.4M
$13.5M
Q3 25
$229.7M
$11.1M
Q2 25
$71.0M
$20.0M
Q1 25
$70.9M
$10.2M
Q4 24
$101.8M
$17.5M
Q3 24
$55.0M
$11.3M
Q2 24
$48.7M
$8.8M
Q1 24
$293.8M
$7.3M
Total Debt
LXP
LXP
VMD
VMD
Q4 25
$1.4B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.6B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
LXP
LXP
VMD
VMD
Q4 25
$2.0B
$141.5M
Q3 25
$2.1B
$133.6M
Q2 25
$2.1B
$139.7M
Q1 25
$2.1B
$134.8M
Q4 24
$2.1B
$131.4M
Q3 24
$2.1B
$125.0M
Q2 24
$2.1B
$119.4M
Q1 24
$2.2B
$116.3M
Total Assets
LXP
LXP
VMD
VMD
Q4 25
$3.5B
$199.2M
Q3 25
$3.7B
$202.4M
Q2 25
$3.7B
$184.6M
Q1 25
$3.8B
$178.1M
Q4 24
$3.8B
$177.1M
Q3 24
$3.9B
$169.5M
Q2 24
$3.9B
$163.9M
Q1 24
$4.2B
$154.9M
Debt / Equity
LXP
LXP
VMD
VMD
Q4 25
0.66×
Q3 25
0.72×
Q2 25
0.72×
Q1 25
0.73×
Q4 24
0.75×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LXP
LXP
VMD
VMD
Operating Cash FlowLast quarter
$188.7M
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
6.56×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LXP
LXP
VMD
VMD
Q4 25
$188.7M
$18.4M
Q3 25
$63.5M
$18.4M
Q2 25
$44.3M
$12.3M
Q1 25
$39.0M
$2.9M
Q4 24
$211.2M
$15.0M
Q3 24
$64.6M
$12.7M
Q2 24
$38.5M
$10.2M
Q1 24
$38.9M
$1.2M
Free Cash Flow
LXP
LXP
VMD
VMD
Q4 25
$9.7M
Q3 25
$10.7M
Q2 25
$4.1M
Q1 25
$-12.6M
Q4 24
$3.2M
Q3 24
$1.7M
Q2 24
$1.2M
Q1 24
$-4.8M
FCF Margin
LXP
LXP
VMD
VMD
Q4 25
12.7%
Q3 25
14.9%
Q2 25
6.5%
Q1 25
-21.4%
Q4 24
5.2%
Q3 24
3.0%
Q2 24
2.3%
Q1 24
-9.5%
Capex Intensity
LXP
LXP
VMD
VMD
Q4 25
11.5%
Q3 25
10.6%
Q2 25
12.9%
Q1 25
26.2%
Q4 24
19.5%
Q3 24
19.0%
Q2 24
16.3%
Q1 24
11.9%
Cash Conversion
LXP
LXP
VMD
VMD
Q4 25
6.56×
3.27×
Q3 25
1.75×
5.23×
Q2 25
1.52×
3.88×
Q1 25
2.05×
1.09×
Q4 24
3.47×
Q3 24
10.18×
3.29×
Q2 24
7.09×
6.94×
Q1 24
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons